The burden of rhinitis in Australia

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/27684
• EU PAS number:
  EUPAS8507
• Study ID:
  27684
• Official title and acronym:
  The burden of rhinitis in Australia
• DARWIN EU® study:
  No
• Study countries:
  Australia
• Study description:
  A set of three studies that aim to evaluate the burden of rhinitis on healthcare in Australia by assessing the real life treatment of rhinitis using prescribing and over the counter information, and the effect of introducing Dymista to the Australian market
• Study status:
  Planned

Research institutions and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 30/01/2015

Study start date

Planned: 06/02/2015

Data analysis start date

Planned: 14/02/2015

Actual: 18/03/2015

Date of final study report

Planned: 31/05/2015

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

MEDA Australia

Study protocol

Initial protocol

R01414_Study 1 Rhinitis treatment patterns_Protocol_2015_V10.For_EnCEPP_02Feb15

Updated protocol

R01414_Study 1 Rhinitis treatment patterns_Protocol_2015_V11

Regulatory

• Was the study required by a regulatory body?:
  Unknown
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable